David R.  Fulton

David R. Fulton, MD

Chief, Division of Cardiology Outpatient Services

Associate Professor of Pediatrics; Tommy Kaplan Chair in Cardiovascular Studies, Harvard Medical School

Medical Services

Specialties

  • Kawasaki Disease

Departments

  • Cardiology
  • Cardiovascular Program

Programs

  • Cardiology Outpatient Services
  • Kawasaki Disease Program
To schedule an appointment: Call 617-355-8162

Experience and Education

Education

Undergraduate School, A.B.

Clark University, 1966 - 1970

Worcester, Ma

Medical School

Cornell University Medical College, 1970 - 1974

New York, NY

Internship

The New York Hospital, 1974 - 1975

New York, NY

Residency, Junior Assistant Resident in Pediatrics

The New York Hospita, 1975 - 1976

New York, NY

Residency, Senior Assistant Resident in Pediatrics

The New York Hospital, 1976 - 1977

New York, NY

Fellowship, Fellow in Cardiology

Boston Children's Hospital, 1977 - 1980

Boston, Ma

Fellowship, Clinical Fellow in Pediatrics

Harvard Medical School, 1977 - 1980

Boston, Ma

Certifications

  • Pediatric Advanced Life Support

  • Pediatric Cardiology

  • Pediatrics

Publications

Publications powered by Harvard Catalyst
  1. Paris Y, Toro-Salazar OH, Gauthier NS, Rotondo KM, Arnold L, Hamershock R, Saudek DE, Fulton DR, Renaud A, Alexander ME. Regional Implementation of a Pediatric Cardiology Syncope Algorithm Using Standardized Clinical Assessment and Management Plans (SCAMPS) Methodology. J Am Heart Assoc. 2016; 5(2).
  2. Ronai C, Baker AL, Friedman KG, Fulton DR, Newburger JW, Lang P. Prevalence of Undiagnosed Structural Heart Disease in Children Undergoing Echocardiography for Kawasaki Disease. Clin Pediatr (Phila). 2016 Jun; 55(6):557-9.
  3. Lewis AB, Martin GR, Bartz PJ, Fischbach PS, Fulton DR, Matherne GP, Reinking B, Spicer RL. Task Force 1: Pediatric Cardiology Fellowship Training in General Cardiology. J Am Coll Cardiol. 2015 Aug 11; 66(6):677-86.
  4. Lewis AB, Martin GR, Bartz PJ, Fischbach PS, Fulton DR, Matherne GP, Reinking B, Spicer RL. Task Force 1: Pediatric Cardiology Fellowship Training in General Cardiology. SPCTPD/ACC/AAP/AHA. Circulation. 2015 Aug 11; 132(6):e48-56.
  5. Angoff GH, Kane DA, Giddins N, Paris YM, Moran AM, Tantengco V, Rotondo KM, Arnold L, Toro-Salazar OH, Gauthier NS, Kanevsky E, Renaud A, Geggel RL, Brown DW, Fulton DR. Regional implementation of a pediatric cardiology chest pain guideline using SCAMPs methodology. Pediatrics. 2013 Oct; 132(4):e1010-7.
  6. Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O'Neill SR, Jaff MR, de Ferranti S, Fulton DR, Colan SD, Newburger JW. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013 Sep 17; 62(12):1114-21.
  7. Muniz JC, Dummer K, Gauvreau K, Colan SD, Fulton DR, Newburger JW. Coronary artery dimensions in febrile children without Kawasaki disease. Circ Cardiovasc Imaging. 2013 Mar 1; 6(2):239-44.
  8. Verghese GR, Friedman KG, Rathod RH, Meiri A, Saleeb SF, Graham DA, Geggel RL, Fulton DR. Resource Utilization Reduction for Evaluation of Chest Pain in Pediatrics Using a Novel Standardized Clinical Assessment and Management Plan (SCAMP). J Am Heart Assoc. 2012 Apr; 1(2).
  9. Evangelista JA, Connor JA, Pintz C, Saia T, O'Connell C, Fulton DR, Hickey P. Paediatric nurse practitioner managed cardiology clinics: patient satisfaction and appointment access. J Adv Nurs. 2012 Oct; 68(10):2165-74.
  10. Farias M, Ziniel S, Rathod RH, Friedman KG, Colan S, Newburger JW, Fulton DR. Provider attitudes toward Standardized Clinical Assessment and Management Plans (SCAMPs). Congenit Heart Dis. 2011 Nov-Dec; 6(6):558-65.
  11. Show all
  12. Friedman KG, Kane DA, Rathod RH, Renaud A, Farias M, Geggel R, Fulton DR, Lock JE, Saleeb SF. Management of pediatric chest pain using a standardized assessment and management plan. Pediatrics. 2011 Aug; 128(2):239-45.
  13. Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW. Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr. 2011 Apr; 158(4):644-649.e1.
  14. Rathod RH, Farias M, Friedman KG, Graham D, Fulton DR, Newburger JW, Colan S, Jenkins K, Lock JE. A novel approach to gathering and acting on relevant clinical information: SCAMPs. Congenit Heart Dis. 2010 Jul-Aug; 5(4):343-53.
  15. Friedman KG, Rathod RH, Farias M, Graham D, Powell AJ, Fulton DR, Newburger JW, Colan SD, Jenkins KJ, Lock JE. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010 Jul-Aug; 5(4):374-81.
  16. Kane DA, Fulton DR, Saleeb S, Zhou J, Lock JE, Geggel RL. Needles in hay: chest pain as the presenting symptom in children with serious underlying cardiac pathology. Congenit Heart Dis. 2010 Jul-Aug; 5(4):366-73.
  17. Newburger JW, Fulton DR. Coronary revascularization in patients with Kawasaki disease. J Pediatr. 2010 Jul; 157(1):8-10.
  18. Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010 Feb; 125(2):e234-41.
  19. Selamet Tierney ES, Newburger JW, Graham D, Baker A, Fulton DR, Colan SD. Diastolic function in children with Kawasaki disease. Int J Cardiol. 2011 May 5; 148(3):309-12.
  20. Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009 Jul; 124(1):1-8.
  21. Miao RQ, Fontana J, Fulton D, Lin MI, Harrison KD, Sessa WC. Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide release and migration in endothelial cells. Arterioscler Thromb Vasc Biol. 2008 Jan; 28(1):105-11.
  22. Newburger JW, Fulton DR. Kawasaki disease. Curr Treat Options Cardiovasc Med. 2007 Apr; 9(2):148-58.
  23. Rhodes J, Curran TJ, Camil L, Rabideau N, Fulton DR, Gauthier NS, Gauvreau K, Jenkins KJ. Sustained effects of cardiac rehabilitation in children with serious congenital heart disease. Pediatrics. 2006 Sep; 118(3):e586-93.
  24. Rhodes J, Curran TJ, Camil L, Rabideau N, Fulton DR, Gauthier NS, Gauvreau K, Jenkins KJ. Impact of cardiac rehabilitation on the exercise function of children with serious congenital heart disease. Pediatrics. 2005 Dec; 116(6):1339-45.
  25. Moniotte S, Geva T, Perez-Atayde A, Fulton DR, Pigula FA, Powell AJ. Images in cardiovascular medicine. Cardiac hemangioma. Circulation. 2005 Aug 23; 112(8):e103-4.
  26. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004 Oct; 16(5):508-14.
  27. Fulton D, Babbitt R, Zoellner S, Fontana J, Acevedo L, McCabe TJ, Iwakiri Y, Sessa WC. Targeting of endothelial nitric-oxide synthase to the cytoplasmic face of the Golgi complex or plasma membrane regulates Akt- versus calcium-dependent mechanisms for nitric oxide release. J Biol Chem. 2004 Jul 16; 279(29):30349-57.
  28. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, Tempst P, Strittmatter SM, Sessa WC. A new role for Nogo as a regulator of vascular remodeling. Nat Med. 2004 Apr; 10(4):382-8.
  29. Papapetropoulos A, Fulton D, Lin MI, Fontana J, McCabe TJ, Zoellner S, García-Cardeña G, Zhou Z, Gratton JP, Sessa WC. Vanadate is a potent activator of endothelial nitric-oxide synthase: evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein. Mol Pharmacol. 2004 Feb; 65(2):407-15.
  30. Lin MI, Fulton D, Babbitt R, Fleming I, Busse R, Pritchard KA, Sessa WC. Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem. 2003 Nov 7; 278(45):44719-26.
  31. Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr. 2003 Jun; 142(6):611-6.
  32. Sowa G, Pypaert M, Fulton D, Sessa WC. The phosphorylation of caveolin-2 on serines 23 and 36 modulates caveolin-1-dependent caveolae formation. Proc Natl Acad Sci U S A. 2003 May 27; 100(11):6511-6.
  33. Baker AL, Gauvreau K, Newburger JW, Sundel RP, Fulton DR, Jenkins KJ. Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics. 2003 Mar; 111(3):579-83.
  34. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, Jo H, Sessa WC. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem. 2003 Apr 25; 278(17):14841-9.
  35. Geggel RL, Horowitz LM, Brown EA, Parsons M, Wang PS, Fulton DR. Parental anxiety associated with referral of a child to a pediatric cardiologist for evaluation of a Still's murmur. J Pediatr. 2002 Jun; 140(6):747-52.
  36. Iwakiri Y, Tsai MH, McCabe TJ, Gratton JP, Fulton D, Groszmann RJ, Sessa WC. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension. Am J Physiol Heart Circ Physiol. 2002 Jun; 282(6):H2084-90.
  37. Scotland RS, Morales-Ruiz M, Chen Y, Yu J, Rudic RD, Fulton D, Gratton JP, Sessa WC. Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res. 2002 May 3; 90(8):904-10.
  38. Fontana J, Fulton D, Chen Y, Fairchild TA, McCabe TJ, Fujita N, Tsuruo T, Sessa WC. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ Res. 2002 May 3; 90(8):866-73.
  39. Jiang X, Zhong WM, Farkas T, Huang PW, Wilton N, Barrett E, Fulton D, Morrow R, Matson DO. Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses. Arch Virol. 2002; 147(1):119-30.
  40. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001 Dec; 299(3):818-24.
  41. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, Sessa WC. Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem. 2002 Feb 8; 277(6):4277-84.
  42. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, Sessa WC. Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem. 2001 Aug 10; 276(32):30359-65.
  43. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)--&gtAsp variant of human endothelial nitric-oxide synthase. J Biol Chem. 2001 Jul 13; 276(28):26674-9.
  44. Ravekes WJ, Colan SD, Gauvreau K, Baker AL, Sundel RP, van der Velde ME, Fulton DR, Newburger JW. Aortic root dilation in Kawasaki disease. Am J Cardiol. 2001 Apr 1; 87(7):919-22.
  45. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res. 2000 Oct 13; 87(8):677-82.
  46. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med. 2000 Sep; 6(9):1004-10.
  47. Luo Z, Fujio Y, Kureishi Y, Rudic RD, Daumerie G, Fulton D, Sessa WC, Walsh K. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest. 2000 Aug; 106(4):493-9.
  48. Fulton DR, Newburger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep. 2000 Aug; 2(4):324-9.
  49. Fulton DR. Early recognition of Munchausen Syndrome by Proxy. Crit Care Nurs Q. 2000 Aug; 23(2):35-42.
  50. Rudic RD, Bucci M, Fulton D, Segal SS, Sessa WC. Temporal events underlying arterial remodeling after chronic flow reduction in mice: correlation of structural changes with a deficit in basal nitric oxide synthesis. Circ Res. 2000 Jun 9; 86(11):1160-6.
  51. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K, Sessa WC. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res. 2000 Apr 28; 86(8):892-6.
  52. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem. 2000 Mar 31; 275(13):9102-5.
  53. McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem. 2000 Mar 3; 275(9):6123-8.
  54. Fulton D, Papapetropoulos A, Zhang X, Catravas JD, Hintze TH, Sessa WC. Quantification of eNOS mRNA in the canine cardiac vasculature by competitive PCR. Am J Physiol Heart Circ Physiol. 2000 Feb; 278(2):H658-65.
  55. Geggel RL, Fulton DR, Rockenmacher S. Nonobstructive cor triatriatum in infancy. Clin Pediatr (Phila). 1999 Aug; 38(8):489-91.
  56. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999 Jun 10; 399(6736):597-601.
  57. Fulton D, Quilley J. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat. J Pharmacol Exp Ther. 1998 Sep; 286(3):1146-51.
  58. Hill SL, Evangelista JK, Pizzi AM, Mobassaleh M, Fulton DR, Berul CI. Proarrhythmia associated with cisapride in children. Pediatrics. 1998 Jun; 101(6):1053-6.
  59. Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol. 1998 Jun; 16(6):2188-94.
  60. Rhodes J, Dave A, Pulling MC, Geggel RL, Marx GR, Fulton DR, Hijazi ZM. Effect of pulmonary artery stenoses on the cardiopulmonary response to exercise following repair of tetralogy of Fallot. Am J Cardiol. 1998 May 15; 81(10):1217-9.
  61. Berul CI, Hill SL, Wang PJ, Marx GR, Fulton DR, Estes NA. Neonatal radiofrequency catheter ablation of junctional tachycardias. J Interv Card Electrophysiol. 1998 Mar; 2(1):91-100.
  62. Berul CI, Hill SL, Geggel RL, Hijazi ZM, Marx GR, Rhodes J, Walsh KA, Fulton DR. Electrocardiographic markers of late sudden death risk in postoperative tetralogy of Fallot children. J Cardiovasc Electrophysiol. 1997 Dec; 8(12):1349-56.
  63. Rhodes J, Warner KG, Fulton DR, Romero BA, Schmid CH, Marx GR. Fate of mitral regurgitation following repair of atrioventricular septal defect. Am J Cardiol. 1997 Nov 1; 80(9):1194-7.
  64. Evangelista JK, Hijazi ZM, Geggel RL, Oates E, Fulton DR. Effect of multiple coil closure of patent ductus arteriosus on blood flow to the left lung as determined by lung perfusion scans. Am J Cardiol. 1997 Jul 15; 80(2):242-4.
  65. Meissner HC, Welliver RC, Chartrand SA, Fulton DR, Rodriguez WJ, Groothuis JR. Prevention of respiratory syncytial virus infection in high risk infants: consensus opinion on the role of immunoprophylaxis with respiratory syncytial virus hyperimmune globulin. Pediatr Infect Dis J. 1996 Dec; 15(12):1059-68.
  66. Rhodes J, Hijazi ZM, Marx GR, Fulton DR. Aerobic exercise function of patients with persistent coronary artery aneurysms secondary to Kawasaki disease. Pediatr Cardiol. 1996 Jul-Aug; 17(4):226-30.
  67. Hijazi ZM, al-Fadley F, Geggel RL, Marx GR, Galal O, al-Halees Z, Abbag F, Fulton DR. Stent implantation for relief of pulmonary artery stenosis: immediate and short-term results. Cathet Cardiovasc Diagn. 1996 May; 38(1):16-23.
  68. Warner KG, Payne DD, Fulton DR, Geggel RL, Marx GR, Schwartz SL, Weintraub AR. Excision of a pulmonary valve abscess in a 61-year-old woman with single ventricle. Ann Thorac Surg. 1996 Jan; 61(1):213-5.
  69. Leung DY, Meissner HC, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol. 1995 Nov; 77(2):119-26.
  70. Fulton DR, Geggel RL. In-hospital mortality for surgical repair of congenital heart defects: preliminary observations of variation by hospital caseload. Pediatrics. 1995 Nov; 96(5 Pt 1):980-1.
  71. Leung DY, Meissner C, Fulton D, Schlievert PM. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol. 1995 Nov; 15(6 Suppl):11S-17S.
  72. Marx GR, Fulton DR, Pandian NG, Vogel M, Cao QL, Ludomirsky A, Delabays A, Sugeng L, Klas B. Delineation of site, relative size and dynamic geometry of atrial septal defects by real-time three-dimensional echocardiography. J Am Coll Cardiol. 1995 Feb; 25(2):482-90.
  73. Hijazi ZM, Udelson JE, Snapper H, Rhodes J, Marx GR, Schwartz SL, Fulton DR. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol. 1994 Dec; 24(7):1633-8.
  74. Cao QL, Pandian NG, Azevedo J, Schwartz SL, Vogel M, Fulton D, Marx G. Enhanced comprehension of dynamic cardiovascular anatomy by three-dimensional echocardiography with the use of mixed shading techniques. Echocardiography. 1994 Nov; 11(6):627-33.
  75. Hijazi ZM, Geggel RL, Aronovitz MJ, Marx GR, Rhodes J, Fulton DR. A new low profile balloon atrial septostomy catheter: initial animal and clinical experience. J Invasive Cardiol. 1994 Jul-Aug; 6(6):209-12.
  76. Fulton DR, Marx GR, Pandian NG, Romero BA, Mumm B, Krauss M, Wollschläger H, Ludomirsky A, Cao QL. Dynamic three-dimensional echocardiographic imaging of congenital heart defects in infants and children by computer-controlled tomographic parallel slicing using a single integrated ultrasound instrument. Echocardiography. 1994 Mar; 11(2):155-64.
  77. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4; 342(8884):1385-8.
  78. Rhodes J, Udelson JE, Marx GR, Schmid CH, Konstam MA, Hijazi ZM, Bova SA, Fulton DR. A new noninvasive method for the estimation of peak dP/dt. Circulation. 1993 Dec; 88(6):2693-9.
  79. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18; 329(21):1524-30.
  80. Hijazi ZM, Aronovitz MJ, Marx GR, Fulton DR. Successful placement and re-expansion of a new balloon expandable stent to maintain patency of the ductus arteriosus in a newborn animal model. J Invasive Cardiol. 1993 Nov-Dec; 5(9):351-7.
  81. Warner KG, Anderson JE, Fulton DR, Payne DD, Geggel RL, Marx GR. Restoration of the pulmonary valve reduces right ventricular volume overload after previous repair of tetralogy of Fallot. Circulation. 1993 Nov; 88(5 Pt 2):II189-97.
  82. Meissner HC, Fulton DR, Groothuis JR, Geggel RL, Marx GR, Hemming VG, Hougen T, Snydman DR. Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. Antimicrob Agents Chemother. 1993 Aug; 37(8):1655-8.
  83. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, Romagne F, Malissen B, Leung DY. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993 Mar 1; 177(3):791-6.
  84. Schwartz SL, Gillam LD, Weintraub AR, Sanzobrino BW, Hirst JA, Hsu TL, Fisher JP, Marx G, Fulton D, McKay RG, et al. Intracardiac echocardiography in humans using a small-sized (6F), low frequency (12.5 MHz) ultrasound catheter. Methods, imaging planes and clinical experience. J Am Coll Cardiol. 1993 Jan; 21(1):189-98.
  85. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr. 1992 Jun; 120(6):926-8.
  86. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 6; 324(23):1633-9.
  87. Hillyer CD, Schwenn MR, Fulton DR, Meissner HC, Berkman EM. Autoimmune hemolytic anemia in Kawasaki disease: a case report. Transfusion. 1990 Oct; 30(8):738-40.
  88. Johnson CE, Vacca CV, Fattlar D, Fulton DJ, Hall PW. Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection. Pediatrics. 1990 Aug; 86(2):211-6.
  89. Blickman JG, Dunlop RW, Fulton DR. Diagnostic implications of the echocardiographically demonstrated pericardial peel. Am Heart J. 1990 Apr; 119(4):965-8.
  90. Fulton DR, Meissner C, Peterson MB. Effects of current therapy of Kawasaki disease on eicosanoid metabolism. Am J Cardiol. 1988 Jun 1; 61(15):1323-7.
  91. Chung KJ, Fulton DR, Lapp R, Spector S, Sahn DJ. One-year follow-up of cardiac and coronary artery disease in infants and children with Kawasaki disease. Am Heart J. 1988 Jun; 115(6):1263-7.
  92. Isner JM, Donaldson RF, Fulton D, Bhan I, Payne DD, Cleveland RJ. Cystic medial necrosis in coarctation of the aorta: a potential factor contributing to adverse consequences observed after percutaneous balloon angioplasty of coarctation sites. Circulation. 1987 Apr; 75(4):689-95.
  93. Geggel RL, Fulton DR, Chernoff HL, Cleveland R, Hougen TJ. Cor triatriatum associated with partial anomalous pulmonary venous connection to the coronary sinus: echocardiographic and angiocardiographic features. Pediatr Cardiol. 1987; 8(4):279-83.
  94. Marchant CD, Shurin PA, Johnson CE, Murdell-Panek D, Feinstein JC, Fulton D, Flexon P, Carlin SA, Van Hare GF. A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr. 1986 Nov; 109(5):891-6.
  95. Fulton DR, Chung KJ, Tabakin BS, Keane JF. Ventricular tachycardia in children without heart disease. Am J Cardiol. 1985 May 1; 55(11):1328-31.
  96. Vincent RN, Lang P, Elixson EM, Gamble WJ, Fulton DR, Fellows KE, Norwood WI, Castaneda AR. Measurement of extravascular lung water in infants and children after cardiac surgery. Am J Cardiol. 1984 Jul 1; 54(1):161-5.
  97. Chung KJ, Fulton DR, Kreidberg MB, Payne DD, Cleveland RJ. Combined discrete subaortic stenosis and ventricular septal defect in infants and children. Am J Cardiol. 1984 May 15; 53(10):1429-32.
  98. Fulton DR, Hougen TJ, Keane JF, Rosenthal AR, Norwood WI, Bernhard WF. Repeat aortic valvotomy in children. Am Heart J. 1983 Jul; 106(1 Pt 1):60-3.
  99. Fulton DR, Grodin M. Pediatric cardiac emergencies. Emerg Med Clin North Am. 1983 Apr; 1(1):45-61.
  100. Chung KJ, Brandt L, Fulton DR, Kreidberg MB. Cardiac and coronary arterial involvement in infants and children from New England with mucocutaneous lymph node syndrome (Kawasaki disease). Angiocardiographic-echocardiographic correlations. Am J Cardiol. 1982 Jul; 50(1):136-42.
To schedule an appointment: Call 617-355-8162

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close